Stevens Institute of Technology - The Innovation University®
UndergraduateGraduate
Give NowLearn about GivingThe Power of Stevens Campaign
Future Student​​Parents and Family MembersStevens Alumnus/a​High School Counselor​Corporate Partner​Current Student​Friend of Stevens Log in to mySTEVENS

Search form

VisitVirtual TourAlumniNewsDirectoryAthleticsmyStevens
    About Stevens
    MissionStevens HistoryFacts & StatisticsRankings and RecognitionLeadershipStrategic PlanSustainabilityCommunity EngagementUniversity Policy LibraryAccreditationConsumer Information
    Admissions
    Undergraduate AdmissionsGraduate AdmissionsStevens Veterans OfficePre-College ProgramsTuition & Financial AidSuccess After Stevens
    Academics
    Undergraduate StudiesGraduate StudiesColleges & SchoolsStevens OnlineAcademic CatalogTechnology & Entrepreneurial ThinkingContinuing and Professional EducationGlobal OpportunitiesAcademic CultureLibrary
    Research & Entrepreneurship
    Foundational Research PillarsAnnual Innovation ExpoFaculty ResearchStudent ResearchInnovation & EntrepreneurshipStevens Venture CenterSolar DecathlonPartner with Stevens
    Campus Life
    Living at Stevens Student Affairs Undergrad Student LifeGraduate Student AffairsCareer Center Health & WellnessDiversity and Inclusion​AthleticsArts on Campus​Life in Hoboken Commencement

Available Patents & Technologies

HomeDirectory Office of Innovation and EntrepreneurshipAvailable Patents & Technologies

Search for Technologies

All Technologies  - Advanced Search   - Algolia Search  

Case ID:
STU-FY19-036

Artificial Cornea with Double-Side-Microtextured pHEMA Hydrogel

Case ID:
STU-FY19-036
Web Published:
2/10/2021
Description:

Artificial Cornea with Double-Side Microtextured pHEMA Hydrogel

Background

As stated by World Health Organization (WHO), over 10 million people suffer from corneal blindness globally and 285 million people are visually impaired; however, only 1/50 of the patients obtained corneal transplants each year worldwide due to lack of donor tissue. In addition, functional defects and heterogeneity of the transplanted cornea commonly occur within a few years of the surgery because of the prevalent use of tissue from older cornea donors. Rejection of donated tissue constitutes another substantive problem in the art.

Overall, full corneal translation from a donor is inefficient and inaccessible for many. A rising geriatric population and the increasing incidence of eye diseases worldwide are expected to be the prime factors driving the demand worldwide for keratoprosthesis (i.e., artificial cornea) treatment.

 

Summary

The present invention relates to an artificial cornea made of Poly(2-hydroxyethyl methacrylate) (pHEMA) hydrogel. The pHEMA is microtextured on both sides to facilitate integration of the artificial cornea with the native tissue of a patient. Specifically, the artificial cornea is designed so that it is biocompatible, driving rapid proliferation of corneal epithelial cells while also enhancing the adhesion of corneal fibroblasts. By fostering its integration with the epithelium as such, the artificial cornea limits the chances of infection, inflammation or extrusion. By integrating with the stroma, the stability of the material within the eye improves. These factors ultimately expedite recovery from surgical implantation. In addition, no donor tissue is required, and the risk of rejection is low. The current artificial cornea products on the market use the stiff materials like Poly(methyl methacrylate) (PMMA), of which Young’s Modulus ranges from 2 to 3 GPa. Stiff materials are likely to increase the risks of tissue extrusion and inflammation. The pHEMA hydrogel is soft but durable with the Young’s Modulus ranging from 1 to 10 MPa, making it ideal for permanent wearing while decreasing discomfort.

 

 

Benefits:

- Promote cell proliferation and adhesion to enhance patient’s recovery speed

- Lower the risk of infection and inflammation post operation

- No tissue rejection due no donor tissue is needed

- Comfortable and safe for life-long usage

- Prevent dryness in patient’s eye

- Thickness and curvature of the artificial cornea can be customized to suit patient’s eye

 

Applications:

- Artificial cornea

- Optical lens implants        

 

Key words:

Hydrogel; microtexturing; artificial cornea; ophthalmology; implants; tissue engineering

 

 

 

Patent Information:
Title App Type Country Serial No. Patent No. File Date Issued Date Expire Date
Direct Link:
https://stevens.testtechnologypublisher.com/technology/16772
STU-FY19-036
Category(s):
Bio Technology (Rx, dev's, sys)
Bookmark this page
Download as PDF
For Information, Contact:
David Zimmerman
Director of Technology Commercialization
Stevens Institute of Technogology
dzimmer3@stevens.edu
Inventors:
Keywords:

A premier, private research university just minutes from New York City with an incredible view and exceptional access to opportunity

© 2018 Stevens Institute of Technology.
All Rights Reserved.
Privacy Policy | Emergency Info

myStevens BookstoreMake a GiftEventsCareers
Our Location

A premier, private research university just minutes from New York City with an incredible view and exceptional access to opportunity

Stevens Institute of Technology

1 Castle Point Terrace
Hoboken, NJ 07030

Get in Touch
201.216.5000
Social Media
FacebookTwitterInstagramYouTubeLinkedInSocial Media Hub